Active Shortage

APO-BROMFENAC

APOTEX INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of APO-BROMFENAC in Canada?

Yes. APO-BROMFENAC 0.07% has an active shortage reported to Health Canada (last updated May 21, 2026).

Why is APO-BROMFENAC not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will APO-BROMFENAC be available again?

The manufacturer's estimated resolution date is March 26, 2027. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusActive Shortage

Same-ingredient products on file3 products

Expected resolution~6 months remaining (estimate)

Affected strength0.07%

Last updated2026-05-21

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

PROLENSA

BAUSCH & LOMB INC

0.07% · DIN 02439123

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

AURO-BROMFENAC

AURO PHARMA INC

0.07% · DIN 02540789

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

EUGIA-BROMFENAC

EUGIA PHARMA INC.

0.07% · DIN 02548259

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

Estimated Resolution

2027-03-26

~6 months remaining (estimate)

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

DIN

02537788

Strength

0.07%

Dosage Form

SOLUTION

Route

OPHTHALMIC

Active Ingredient

BROMFENAC

Tier

Unrated

Last Updated

2026-05-21

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Other Products from APOTEX INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

24HR NASAL ALLERGY RELIEF

50MCG · DIN 02460513

ACETAMINOPHEN CAPLETS 325 MG

325MG · DIN 02362341

ACETAMINOPHEN CAPLETS 500 MG

500MG · DIN 02362368

ACETAMINOPHEN HEADACHE ULTRA RELIEF

DIN 02290901

ACETAMINOPHEN TABLETS USP 325 MG

325MG · DIN 02362422

ACETAMINOPHEN TABLETS USP 500 MG

500MG · DIN 02362244